The drug:membrane interactions for the antihypertensive AT1 antagonist losartan, the prototype of the sartans class, were studied using an integrated approach [1] . Through studying a. the drug pharmacophore arrangement in solution environments mimicking biological conditions and b. drug: membrane interactions in modelled micellar aggregates and DPPC bilayers with the AT1 receptor embedded, we provide significant insights into the bioactive conformation of losartan, an atomic-level description of the losartan-membrane interactions and partitioning into the membrane as well as investigate the potential pathways of entrance towards the AT1 active site. The conformational features and dynamics of the drug were investigated in DMSO, D 2 O and SDS micelles. Using intermolecular ROE interactions and NMR relaxation probes we have further elucidated the drug topography in the micellar aggregate and the preferred orientation of the flexible pharmacophores. MD simulations in both micellar and lipid bilayers with the AT1 receptor embedded provided strong evidence i for the spontaneous insertion of losartan in the lipidic core. Moreover, a long exploratory unbiased MD run (580 ns) in the membrane:receptor modelled system enabled the monitoring of the diffusion pathways of the drug and the intermolecular interactions. The validity of our integrated approach is evidenced by the remarkable convergence of the experimental and the theoretical data. The aqueous-membrane "walk" of losartan at atomic resolution was implemented as a continuation to our previous studies on the interactions of the amphiphiles AT 1 antagonists with membranes and the possible implication of the latter in the effective interaction of the drug with its transmembrane target [2] [3] [4] .
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